vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and SFL Corp Ltd. (SFL). Click either name above to swap in a different company.
SFL Corp Ltd. is the larger business by last-quarter revenue ($353.7M vs $270.8M, roughly 1.3× HUTCHMED (China) Ltd). SFL Corp Ltd. runs the higher net margin — 1.1% vs 0.7%, a 0.4% gap on every dollar of revenue. On growth, HUTCHMED (China) Ltd posted the faster year-over-year revenue change (-16.5% vs -27.0%).
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
SFL Corp Ltd is a global maritime transportation and vessel owning enterprise with a diversified fleet including container ships, oil tankers, dry bulk carriers and offshore support vessels. It serves international logistics, energy and bulk commodity sectors, offering long-term and spot charter services to clients across major global trade routes.
HCM vs SFL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $353.7M |
| Net Profit | $2.0M | $4.0M |
| Gross Margin | 37.7% | — |
| Operating Margin | -13.2% | 22.8% |
| Net Margin | 0.7% | 1.1% |
| Revenue YoY | -16.5% | -27.0% |
| Net Profit YoY | -83.6% | -93.9% |
| EPS (diluted) | $0.00 | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.8M | $353.7M | ||
| Q2 25 | $277.7M | — | ||
| Q1 25 | $324.5M | — | ||
| Q4 24 | — | $484.4M | ||
| Q2 24 | $305.7M | — | ||
| Q4 23 | — | $414.5M | ||
| Q2 23 | $532.9M | — | ||
| Q4 22 | — | $364.7M |
| Q4 25 | $2.0M | $4.0M | ||
| Q2 25 | $455.0M | — | ||
| Q1 25 | $11.9M | — | ||
| Q4 24 | — | $64.7M | ||
| Q2 24 | $25.8M | — | ||
| Q4 23 | — | $60.7M | ||
| Q2 23 | $168.6M | — | ||
| Q4 22 | — | $98.3M |
| Q4 25 | 37.7% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 48.0% | — | ||
| Q4 24 | — | — | ||
| Q2 24 | 41.1% | — | ||
| Q4 23 | — | — | ||
| Q2 23 | 0.0% | — | ||
| Q4 22 | — | — |
| Q4 25 | -13.2% | 22.8% | ||
| Q2 25 | -1.3% | — | ||
| Q1 25 | -5.0% | — | ||
| Q4 24 | — | 32.8% | ||
| Q2 24 | -9.0% | — | ||
| Q4 23 | — | 33.4% | ||
| Q2 23 | 21.0% | — | ||
| Q4 22 | — | 38.3% |
| Q4 25 | 0.7% | 1.1% | ||
| Q2 25 | 163.8% | — | ||
| Q1 25 | 3.7% | — | ||
| Q4 24 | — | 13.4% | ||
| Q2 24 | 8.4% | — | ||
| Q4 23 | — | 14.6% | ||
| Q2 23 | 31.6% | — | ||
| Q4 22 | — | 27.0% |
| Q4 25 | $0.00 | $0.03 | ||
| Q2 25 | $0.52 | — | ||
| Q1 25 | $0.01 | — | ||
| Q4 24 | — | $0.49 | ||
| Q2 24 | $0.03 | — | ||
| Q4 23 | — | $0.48 | ||
| Q2 23 | $0.19 | — | ||
| Q4 22 | — | $0.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $150.8M |
| Total DebtLower is stronger | $93.2M | $2.6B |
| Stockholders' EquityBook value | $1.2B | $960.9M |
| Total Assets | $1.8B | $3.6B |
| Debt / EquityLower = less leverage | 0.08× | 2.69× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4B | $150.8M | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $836.1M | — | ||
| Q4 24 | — | $134.6M | ||
| Q2 24 | $802.5M | — | ||
| Q4 23 | — | $165.5M | ||
| Q2 23 | $856.2M | — | ||
| Q4 22 | — | $188.4M |
| Q4 25 | $93.2M | $2.6B | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q4 24 | — | $2.9B | ||
| Q2 24 | $82.1M | — | ||
| Q4 23 | — | $2.2B | ||
| Q2 23 | $40.1M | — | ||
| Q4 22 | — | $2.2B |
| Q4 25 | $1.2B | $960.9M | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $759.9M | — | ||
| Q4 24 | — | $1.1B | ||
| Q2 24 | $740.1M | — | ||
| Q4 23 | — | $1.0B | ||
| Q2 23 | $782.0M | — | ||
| Q4 22 | — | $1.1B |
| Q4 25 | $1.8B | $3.6B | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | — | $4.1B | ||
| Q2 24 | $1.3B | — | ||
| Q4 23 | — | $3.7B | ||
| Q2 23 | $1.3B | — | ||
| Q4 22 | — | $3.9B |
| Q4 25 | 0.08× | 2.69× | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | — | 2.54× | ||
| Q2 24 | 0.11× | — | ||
| Q4 23 | — | 2.08× | ||
| Q2 23 | 0.05× | — | ||
| Q4 22 | — | 2.03× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $118.4M |
| Free Cash FlowOCF − Capex | $3.4M | — |
| FCF MarginFCF / Revenue | 1.2% | — |
| Capex IntensityCapex / Revenue | 1.8% | — |
| Cash ConversionOCF / Net Profit | 4.21× | 29.75× |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $118.4M | ||
| Q2 25 | $-72.9M | — | ||
| Q1 25 | $40.3M | — | ||
| Q4 24 | — | $182.4M | ||
| Q2 24 | $-39.8M | — | ||
| Q4 23 | — | $112.1M | ||
| Q2 23 | $226.4M | — | ||
| Q4 22 | — | $188.4M |
| Q4 25 | $3.4M | — | ||
| Q2 25 | $-82.2M | — | ||
| Q1 25 | $32.5M | — | ||
| Q4 24 | — | — | ||
| Q2 24 | $-49.9M | — | ||
| Q4 23 | — | — | ||
| Q2 23 | $202.0M | — | ||
| Q4 22 | — | — |
| Q4 25 | 1.2% | — | ||
| Q2 25 | -29.6% | — | ||
| Q1 25 | 10.0% | — | ||
| Q4 24 | — | — | ||
| Q2 24 | -16.3% | — | ||
| Q4 23 | — | — | ||
| Q2 23 | 37.9% | — | ||
| Q4 22 | — | — |
| Q4 25 | 1.8% | — | ||
| Q2 25 | 3.3% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | — | — | ||
| Q2 24 | 3.3% | — | ||
| Q4 23 | — | — | ||
| Q2 23 | 4.6% | — | ||
| Q4 22 | — | — |
| Q4 25 | 4.21× | 29.75× | ||
| Q2 25 | -0.16× | — | ||
| Q1 25 | 3.38× | — | ||
| Q4 24 | — | 2.82× | ||
| Q2 24 | -1.54× | — | ||
| Q4 23 | — | 1.85× | ||
| Q2 23 | 1.34× | — | ||
| Q4 22 | — | 1.92× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
